These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
401 related items for PubMed ID: 19485793
21. Indications for therapy in hepatitis B. Degertekin B, Lok AS. Hepatology; 2009 May; 49(5 Suppl):S129-37. PubMed ID: 19399799 [Abstract] [Full Text] [Related]
22. A proposed, evidence-based approach to the treatment of chronic Hepatitis B. Han SH, Durazo FA, Saab S, Tong MJ. J Clin Gastroenterol; 2011 Mar; 45(3):259-66. PubMed ID: 20856136 [Abstract] [Full Text] [Related]
23. [Effects of lamivudine on cirrhotic patients following chronic hepatitis B]. Lin XF, Lin XY, Han QX, Wang JH. Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):304. PubMed ID: 12223149 [No Abstract] [Full Text] [Related]
24. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy. Chehadeh W, Al-Nakib W. J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842 [Abstract] [Full Text] [Related]
25. Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis. Zoutendijk R, Reijnders JG, Zoulim F, Brown A, Mutimer DJ, Deterding K, Hofmann WP, Petersen J, Fasano M, Buti M, Berg T, Hansen BE, Sonneveld MJ, Wedemeyer H, Janssen HL, VIRGIL Surveillance Study Group. Gut; 2013 May; 62(5):760-5. PubMed ID: 22490523 [Abstract] [Full Text] [Related]
26. Halting the natural history of hepatitis B viral infection: a paradigm shift. Perrillo RP, Jacobson IM. Semin Liver Dis; 2007 Aug; 27 Suppl 1():3-8. PubMed ID: 17701844 [Abstract] [Full Text] [Related]
27. Antiviral therapy for hepatitis B virus-related decompensated cirrhosis. Wang JY. J Dig Dis; 2012 Nov; 13(11):555-7. PubMed ID: 23107441 [Abstract] [Full Text] [Related]
29. [Lamivudine treatment of patients with decompensated HBV cirrhosis and mutation in YMDD motif]. Wei L. Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):77-8. PubMed ID: 15670511 [No Abstract] [Full Text] [Related]
30. [Long-term therapy with nucleoside analog entecavir (baraclude) in patients with chronic hepatitis B]. Pawłowska M, Halota W. Przegl Epidemiol; 2011 Jan; 65(2):313-7. PubMed ID: 21913482 [Abstract] [Full Text] [Related]
35. Does treatment with interferon-based therapy improve the natural history of chronic hepatitis B infection? Lau GK. J Hepatol; 2007 Jan; 46(1):6-8. PubMed ID: 17112628 [No Abstract] [Full Text] [Related]
36. Therapeutic strategies for chronic hepatitis B virus infection in 2008. Khokhar A, Afdhal NH. Am J Med; 2008 Dec; 121(12 Suppl):S33-44. PubMed ID: 19185073 [Abstract] [Full Text] [Related]
37. End points of therapy in chronic hepatitis B. Ahmed SN, Ecochard M, Zoulim F. Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):37-49. PubMed ID: 20136588 [Abstract] [Full Text] [Related]
38. Does antiviral therapy reduce complications of cirrhosis? Chung GE, Lee JH, Kim YJ. World J Gastroenterol; 2014 Jun 21; 20(23):7306-11. PubMed ID: 24966601 [Abstract] [Full Text] [Related]
39. Treatment of chronic hepatitis B: recommendations from an Italian workshop. Carosi G, Rizzetto M. Dig Liver Dis; 2008 Aug 21; 40(8):603-17. PubMed ID: 18499540 [Abstract] [Full Text] [Related]